Advertisement

Archive for Monday, April 4, 2011

KU School of Pharmacy ranks 4th in NIH funding

April 4, 2011, 6:33 p.m. Updated April 5, 2011, 1:56 p.m.

Advertisement

Kansas University’s School of Pharmacy ranked fourth in the nation in funding from the National Institutes of Health among schools of pharmacy.

The American Association of Colleges of Pharmacy reported that KU received more than $18.4 million in NIH funding in the 2010 fiscal year.

The University of California-San Francisco's pharmacy school was ranked at the top of the list.

KU also ranked in the top 10 for percentage of full-time faculty members who receive NIH funding. In fiscal year 2010, 45 percent of KU’s 40 pharmacy professors received funding.

“It’s about four decades we’ve been ranked now,” said Ken Audus, KU’s dean of its School of Pharmacy, and KU has been among the top 10 for the last 10 years.

Jeff Aube is a professor of medicinal chemistry who leads research teams on two major grants that bring in millions of dollars of annual funding.

Still, he said, looking simply at the total dollar amount funded might not be the best way to judge a school’s performance.

“Just because research is more expensive, that doesn’t necessarily mean that it’s better,” he said.

But looking at NIH funding is still a good indicator of success, he said, largely because of stringent peer-review panels.

Today, about 10 percent of all proposals receive NIH funds.

“You basically have to be at the top of the game and have ideas that are really relevant and be able to communicate that in a very effective way and convince your peers you’re worthy of funding,” Audus said.

Comments

devobrun 3 years, 8 months ago

Actually, you have to have friends at NIH and other institutions who review your work favorably. If you have a good program, you produce young researchers who go to other institutions, or stay at KU. But they grow to positions of authority such that they contribute to the maintenance of the system. You and your fellows rotate from KU to NIH (on sabbatical) to review and run NIH programs. You scratch the backs of the people at the institutions you fund when you are a program director at NIH. Then you return to KU and and the folks you funded go to NIH and run programs that fund your research. It is scientific incest.
The success of KU School of Pharma is a testament to its skill at the top. The top profs are clearly playing the game well. Congratulations.

Commenting has been disabled for this item.